Limb and cardiovascular event risk in type 1 and 2 diabetic patients with peripheral artery disease

被引:0
|
作者
Sykora, Daniel [1 ]
Firth, Christine [2 ]
Girardo, Marlene [3 ]
Tseng, Andrew [4 ]
Wennberg, Paul [5 ]
Liedl, David [5 ]
Shamoun, Fadi [2 ]
机构
[1] Mayo Clin, Sch Grad Med Educ, Rochester, MN USA
[2] Mayo Clin, Dept Cardiovasc Dis, Phoenix, AZ USA
[3] Mayo Clin, Div Hlth Sci Res, Dept Biomed Stat & Informat, Scottsdale, AZ USA
[4] Mayo Clin, Dept Cardiovasc Dis, Jacksonville, FL USA
[5] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA
关键词
Peripheral artery disease (PAD); lower extremity artery disease; diabetes mellitus; limb ischemia; type; 1; diabetes; 2; MORTALITY; ASSOCIATION; PREVALENCE; MANAGEMENT;
D O I
10.1024/0301-1526/a001086
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Peripheral artery disease (PAD) is a risk factor for adverse limb events (LE) and cardiovascular events (CVE) that coexists with type 1 (T1) and 2 (T2) diabetes mellitus (DM). Little is known about comparative risk of LE and CVE in T1/T2 DM patients with PAD. Patients and methods: We queried our database of 40,144 patients >= 18 years old who underwent ankle brachial index (ABI) measurement from 01/1996-02/2020. We isolated T1/T2 DM patients with PAD diagnosed by ankle brachial index (ABI; low [<1.0] or elevated [>1.4]) and retrieved demographics including glycated hemoglobin (HbA1c). Primary outcomes were LE (critical limb ischemia/vascular amputation) and CVE (myocardial infarction/ ischemic stroke). All-cause mortality was a secondary outcome. Multivariable Cox proportional regression yielded hazard ratios (HR) with 95% confidence intervals (CI) after adjusting for pertinent risk factors including age, hypertension, hyperlipidemia, smoking, and HbA1c. Results: Our study found 10,156 patients with PAD and DM (34% T1DM, 66% T2DM) with median follow-up time 34 mo (IQR 85 mo). T1DM patients were younger than T2DM (mean age 67 vs. 70 years), with higher median HbA1c (7.7 [IQR 1.9] vs. 6.7% [IQR 1.6]), and more prevalent hypertension, hyperlipidemia, CAD, and CKD. Antiplatelet and statin use was equivocal. Elevated ABI was more common in T1DM (47 vs. 28%). LE occurred in 23% and CVE in 12% patients. LE risk was higher in T1 than T2 DM patients (HR 1.58 [95% CI 1.44, 1.73], p<0.0001), but CVE and all-cause mortality were equivocal. These observations were preserved across ABI and HbA1c subgroup analyses. Conclusions: PAD patients with T1DM had a higher LE risk than those with T2DM, even after adjustment for glycemic control and pertinent risk factors, but CVE risk and all-cause mortality were equivocal. These data suggest a potential role for more intensive LE risk modification in PAD patients with T1DM, but further investigation is needed.
引用
收藏
页码:310 / 316
页数:7
相关论文
共 50 条
  • [41] Peripheral Artery Disease in Type 2 Diabetic Patients from the United Arab Emirates
    Al-Kaabi, Juma M.
    Al Maskari, Fatma
    Zoubeidi, Taoufik
    Abdulle, Abdishakur
    Shah, Syed M.
    Cragg, Paul
    Afandi, Bachar
    Souid, Abdul-Kader
    JOURNAL OF DIABETES & METABOLISM, 2014, 5 (06)
  • [42] Individuals with Peripheral Artery Disease (PAD) and Type 1 Diabetes Are More Likely to Undergo Limb Amputation than Those with PAD and Type 2 Diabetes
    Jain, Nidhi
    Agarwal, Manyoo A.
    Jalal, Diana
    Dokun, Ayotunde O.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 10
  • [43] Cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients with peripheral artery disease
    Luís Henrique Canani
    Eduardo Copstein
    Miriam Pecis
    Rogério Friedman
    Cristiane Bauermann Leitão
    Mirela Jobim Azevedo
    Cristina Triches
    Dimitris Rucks Varvaki Rados
    Ruy Silveira Moreas
    Jorge Luiz Gross
    Diabetology & Metabolic Syndrome, 5
  • [44] Increased risk of cardiovascular disease in newly diagnosed type 2 diabetic patients in a primary health care center in Trinidad
    Ezenwaka, CE
    Davis, G
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 50 (02) : 137 - 145
  • [45] Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients
    Nybo, M.
    Poulsen, M. K.
    Grauslund, J.
    Henriksen, J. E.
    Rasmussen, L. M.
    DIABETIC MEDICINE, 2010, 27 (03) : 289 - 294
  • [46] Benefits of Taurisolo in Diabetic Patients with Peripheral Artery Disease
    Amato, Bruno
    Novellino, Ettore
    Morlando, Davide
    Vanoli, Camilla
    Vanoli, Emilio
    Ferrara, Fulvio
    Difruscolo, Rossana
    Goffredo, Vito Maria
    Compagna, Rita
    Tenore, Gian Carlo
    Stornaiuolo, Mariano
    Fordellone, Mario
    Caradonna, Eugenio
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (06)
  • [47] Cardiovascular autonomic neuropathy and incident diabetic kidney disease in patients with type 2 diabetes
    Jun, Ji Eun
    Choi, Min Sun
    Kim, Jae Hyeon
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 184
  • [48] Peripheral Neuropathy as a Risk Factor for Developing Cardiovascular Disease in Diabetic Patients
    AlGhamdi, Ghassan
    Saati, Hisham
    Almotairi, Enad
    Alsofiani, Basil S.
    Kinsara, Abdulhalim J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
  • [49] Ultrasound-detected tibial artery calcification as a marker of cardiovascular and lower-limb risk in asymptomatic patients with type-2diabetes
    Salle, Laurence
    Magne, Julien
    Kenne Malaha, Angeladine
    Chastaingt, Lucie
    Galinat, Sophie
    Drutel, Anne
    Lacroix, Philippe
    Teissier-Clement, Marie-Pierre
    Aboyans, Victor
    VASCULAR MEDICINE, 2023, 28 (06) : 538 - 546
  • [50] Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes
    Fujisawa, Keiko
    Katakami, Naoto
    Kaneto, Hideaki
    Naka, Toyoko
    Takahara, Mitsuyoshi
    Sakamoto, Fumie
    Irie, Yoko
    Miyashita, Kazuyuki
    Kubo, Fumiyo
    Yasuda, Tetsuyuki
    Matsuoka, Taka-aki
    Shimomura, Iichiro
    ATHEROSCLEROSIS, 2013, 227 (02) : 425 - 428